Bimonthly Business magazine
Bimonthly Business magazine
• The biotechnology market in the GCC is projected to reach $2.6 billion by 2028, with the UAE and Saudi Arabia leading the growth in the region; the global market is expected to reach over US$4 trillion in 2028
• Biotechnology and life sciences serve as a strategic bridge, connecting cutting-edge research with real-world healthcare transformation
• World Health Expo (WHX) in Dubai, formerly Arab Health, will take place at the Dubai Exhibition Centre from 9-12 February 2026, welcoming more than 235,000 professional visits and 4,300 exhibitors at the largest healthcare event in 2026
Dubai, United Arab Emirates, XX December 2025: World Health Expo (WHX) in Dubai, formerly Arab Health, which takes place from 9-12 February 2026 at the Dubai Exhibition Centre (DEC), has officially announced the launch of a new dedicated Biotech & Life Sciences zone in recognition of the sector’s expansion, which is expected to exceed US$4 trillion globally by 2035.
The introduction of the new zone reflects the unprecedented acceleration across the global biotechnology industry, which uses living organisms, cells, or biological processes to develop products and technologies for treating, preventing, and diagnosing human diseases. Breakthroughs in areas such as advanced therapeutics, AI-driven research and development, translational science, clinical innovation, and sustainable biomanufacturing are shaping the market.
According to Global Data Route Analytics, a leading business intelligence firm, the global biotechnology market was valued at US$1.6 trillion in 2020 and is expected to grow at a compound annual growth rate of 14.2% until 2035, reaching US$4.05 trillion.
Furthermore, a recent report from Knight Frank highlights the trajectory of the GCC biotechnology market, projected to reach US$2.6 billion by 2028. Leading this growth are the UAE and Saudi Arabia, driven by a surge in localised R&D activities in areas such as genomics, oncology, rare diseases, and synthetic biology. This momentum is further fuelled by an increasing investor appetite and enhanced cross-border collaboration as the industry transitions from early discovery to commercial-stage innovation.
Aligning with this growth, the inaugural Biotech & Life Sciences Zone, which will take place on 9 February 2026 as part of the newly introduced Frontiers Stage at WHX in Dubai, will convene global experts, regional innovators, policymakers, investors and industry leaders.
Held under the theme Where Science Meets the Future, the Biotech & Life Sciences Zone will feature keynote addresses, panel discussions and fireside chats addressing global biotech investment, translational research, cell and gene therapies, sustainability and the future of humanity.
In 2026, WHX in Dubai will be co-timed with WHX Labs in Dubai (formerly Medlab Middle East), creating a city-wide healthcare experience across Expo City Dubai and Dubai World Trade Centre.
WHX in Dubai and WHX Labs in Dubai are held under the patronage of the UAE Ministry of Health and Prevention.
For more information or to register for the event, please visit:
www.worldhealthexpo.com
NewsLetter Sign Up !
To unsubsribe please click here ».